Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Molecular Endocrinology (Baltimore, Md.)|July 5, 2005
Regulation of protein kinase B tyrosine phosphorylation by thyroid-specific oncogenic RET/PTC kinasesHye Sook Jung, Dong Wook Kim, Young Suk Jo, et al.
American Journal of Translational Research|December 2, 2016
An engineered FGF21 variant, LY2405319, can prevent non-alcoholic steatohepatitis by enhancing hepatic mitochondrial functionJu Hee Lee, Yea Eun Kang, Joon Young Chang, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cellsJung Hwan Hwang, Jin Hee Hwang, Hyo Kyun Chung, et al.
Molecular Endocrinology (Baltimore, Md.)|March 15, 2003
Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformationJung Hwan Hwang, Dong Wook Kim, Jae Mi Suh, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 3, 2014
The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammationHyo Kyun Chung, Yong Kyung Kim, Ji-Hoon Park, et al.
The Journal of Biological Chemistry|April 2, 2003
Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid glandJae Mi Suh, Jung Hun Song, Dong Wook Kim, et al.
Molecular Endocrinology (Baltimore, Md.)|May 10, 2003
RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1Dong Wook Kim, Jung Hwan Hwang, Jae Mi Suh, et al.
Molecular Endocrinology (Baltimore, Md.)|October 2, 2004
CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its transactivationKi Cheol Park, Kwang-Hoon Song, Hyo Kyun Chung, et al.
BMB Reports|January 8, 2014
Role of NADH: quinone oxidoreductase-1 in the tight junctions of colonic epithelial cellsSeung Taek Nam, Jung Hwan Hwang, Dae Hong Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|July 20, 2006
An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinasesDong Wook Kim, Young Suk Jo, Hye Sook Jung, et al.
Pageof 4